QQQ   432.26 (-1.37%)
AAPL   172.71 (-2.18%)
MSFT   414.50 (-1.75%)
META   498.66 (-2.59%)
GOOGL   155.25 (-1.57%)
AMZN   183.74 (-1.28%)
TSLA   162.91 (-4.76%)
NVDA   867.59 (-1.62%)
AMD   159.90 (-2.07%)
NIO   3.86 (-6.08%)
BABA   70.60 (-0.97%)
T   16.20 (-0.67%)
F   12.28 (-2.62%)
MU   121.35 (-0.95%)
GE   153.20 (-0.92%)
CGC   7.04 (-9.74%)
DIS   113.32 (-0.61%)
AMC   2.54 (-4.15%)
PFE   25.93 (+0.27%)
PYPL   63.71 (-1.36%)
XOM   119.54 (-0.69%)
QQQ   432.26 (-1.37%)
AAPL   172.71 (-2.18%)
MSFT   414.50 (-1.75%)
META   498.66 (-2.59%)
GOOGL   155.25 (-1.57%)
AMZN   183.74 (-1.28%)
TSLA   162.91 (-4.76%)
NVDA   867.59 (-1.62%)
AMD   159.90 (-2.07%)
NIO   3.86 (-6.08%)
BABA   70.60 (-0.97%)
T   16.20 (-0.67%)
F   12.28 (-2.62%)
MU   121.35 (-0.95%)
GE   153.20 (-0.92%)
CGC   7.04 (-9.74%)
DIS   113.32 (-0.61%)
AMC   2.54 (-4.15%)
PFE   25.93 (+0.27%)
PYPL   63.71 (-1.36%)
XOM   119.54 (-0.69%)
QQQ   432.26 (-1.37%)
AAPL   172.71 (-2.18%)
MSFT   414.50 (-1.75%)
META   498.66 (-2.59%)
GOOGL   155.25 (-1.57%)
AMZN   183.74 (-1.28%)
TSLA   162.91 (-4.76%)
NVDA   867.59 (-1.62%)
AMD   159.90 (-2.07%)
NIO   3.86 (-6.08%)
BABA   70.60 (-0.97%)
T   16.20 (-0.67%)
F   12.28 (-2.62%)
MU   121.35 (-0.95%)
GE   153.20 (-0.92%)
CGC   7.04 (-9.74%)
DIS   113.32 (-0.61%)
AMC   2.54 (-4.15%)
PFE   25.93 (+0.27%)
PYPL   63.71 (-1.36%)
XOM   119.54 (-0.69%)
QQQ   432.26 (-1.37%)
AAPL   172.71 (-2.18%)
MSFT   414.50 (-1.75%)
META   498.66 (-2.59%)
GOOGL   155.25 (-1.57%)
AMZN   183.74 (-1.28%)
TSLA   162.91 (-4.76%)
NVDA   867.59 (-1.62%)
AMD   159.90 (-2.07%)
NIO   3.86 (-6.08%)
BABA   70.60 (-0.97%)
T   16.20 (-0.67%)
F   12.28 (-2.62%)
MU   121.35 (-0.95%)
GE   153.20 (-0.92%)
CGC   7.04 (-9.74%)
DIS   113.32 (-0.61%)
AMC   2.54 (-4.15%)
PFE   25.93 (+0.27%)
PYPL   63.71 (-1.36%)
XOM   119.54 (-0.69%)

60 Degrees Pharmaceuticals (SXTP) SEC Filings & 10K Form

$0.25
-0.01 (-4.33%)
(As of 01:55 PM ET)

Recent 60 Degrees Pharmaceuticals SEC Filings

DateFilerForm TypeView
04/03/2024
5:00 PM
60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
Knight Therapeutics Inc (Reporting)
KNIGHT THERAPEUTICS INTERNATIONAL SA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
1:32 PM
60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/02/2024
2:31 PM
60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
XU CHERYL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
2:33 PM
60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
DOW GEOFFREY S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2024
11:15 PM
60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form EFFECT
01/22/2024
4:01 PM
60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/16/2024
1:56 PM
60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2023
9:29 AM
60 Degrees Pharmaceuticals (Subject)
60 DEGREES PHARMACEUTICALS, INC. (Subject)
KNIGHT THERAPEUTICS INTERNATIONAL SA (Filed by)
Form SC 13G
12/18/2023
8:23 AM
60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
Knight Therapeutics Inc (Reporting)
KNIGHT THERAPEUTICS INTERNATIONAL SA (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/20/2023
11:41 AM
60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/15/2023
4:14 PM
60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form NT 10-Q
10/12/2023
3:17 PM
60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2023
3:31 PM
60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/25/2023
2:26 PM
60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/17/2023
3:08 PM
60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/13/2023
11:37 AM
60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 424B4
07/12/2023
1:51 PM
60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
DOW GEOFFREY S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2023
1:54 PM
60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
MILLER TYRONE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2023
10:41 AM
60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form CERT
07/11/2023
11:15 PM
60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form EFFECT
07/11/2023
8:21 PM
60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
XU CHERYL (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/11/2023
8:11 PM
60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
DOW GEOFFREY S (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/11/2023
8:13 PM
60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
Allen Charles W (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/11/2023
8:16 PM
60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
TOOVEY STEPHEN (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/11/2023
8:18 PM
60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
FIELD PAUL (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/11/2023
7:58 PM
60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
SMITH BRYAN LEE (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/11/2023
8:02 PM
60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
MILLER TYRONE (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/11/2023
8:05 PM
60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
KENTUCKY TECHNOLOGY INC. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/11/2023
8:08 PM
60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
Florida State University Research Foundation Inc. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/27/2023
11:51 AM
60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 8-A12B/A
06/14/2023
11:22 AM
60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 8-A12B/A
06/01/2023
1:53 PM
60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form S-1/A
05/24/2023
4:21 PM
60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form D
Notice of Exempt Offering of Securities 
04/28/2023
3:47 PM
60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form S-1/A
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:SXTP) was last updated on 4/15/2024 by MarketBeat.com Staff

From Our Partners